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We report a carbohydrate microarray-based
approach for the rapid, facile analysis of glycos-
aminoglycan-protein interactions. The key
structural determinants responsible for protein
binding, such as sulfate groups that participate
in the interactions, were elucidated. Specific-
ities were also readily compared across protein
families or functional classes, and comparisons
among glycosaminoglycan subclasses pro-
vided a more comprehensive understanding of
protein specificity. To validate the approach,
we showed that fibroblast growth factor family
members have distinct sulfation preferences.
We also demonstrated that heparan sulfate
and chondroitin sulfate interact in a sulfation-
dependent manner with various axon guidance
proteins, including slit2, netrin1, ephrinA1,
ephrinA5, and semaphorin5B. We anticipate
that these microarrays will accelerate the dis-
covery of glycosaminoglycan-binding proteins
and provide a deeper understanding of their
roles in regulating diverse biological processes.
INTRODUCTION
Heparin and heparan sulfate (HS) glycosaminoglycans
play important roles in many physiological and pathologi-
cal processes such as cell growth, viral invasion, angio-
genesis, and cancer. The chemical diversity of HS, repre-
sented by varied stereochemistries and sulfation patterns,
is believed to have important functional consequences,
enabling a large number of protein-binding motifs to be
generated from a relatively simple scaffold [1, 2]. Indeed,
glycosaminoglycans have been shown to interact with
a wide range of proteins, including growth factors, metal-
loproteinases, chemokines, and pathogenic proteins [1,
2]. Despite intense study, the precise sequences involved
in protein recognition are understood only in a few cases
[3–5]. Elucidating the sulfation specificities of the growingChemistry & Biology 14, 195–2number of HS-binding proteins in the genome will be
critical for understanding the structure-activity relation-
ships of glycosaminoglycans and the molecular mecha-
nisms underlying important biological processes.
Several powerful methods have been developed to
study glycosaminoglycan-protein interactions [6]. Typi-
cally, small oligosaccharide libraries are created from nat-
urally occurring polysaccharides by heparinase treatment
and, in some cases, chemical desulfation followed by
resulfation with various sulfotransferase enzymes [6–8].
The oligosaccharides are then radiolabeled, and HS-
protein interactions are evaluated by affinity chromatogra-
phy or electrophoretic mobility shift assays [7, 9–11]. Alter-
natively, indirect competition assays have been used to
determine the sulfation specificities of proteins by using
free heparin of varying sulfation patterns to disrupt the
binding of proteins to immobilized heparin [6, 12]. Mass
spectrometry has been applied recently to characterize
the binding of HS to certain proteins, such as chemokine
ligand 2 and fibroblast growth factor-2 (FGF2) [13, 14].
Finally, surface plasmon resonance and isothermal calo-
rimetry have been exploited to provide quantitative infor-
mation about HS-protein interactions [15–17]. Although
effective, none of these methods is ideally suited to the
direct, high-throughput analysis of glycosaminoglycan-
protein interactions. Existing approaches are generally
labor intensive, require specialized equipment, consume
significant amounts of carbohydrate or protein, and/or
involve handling of expensive radioactive materials. Given
the large number of binding partners and diverse glycos-
aminoglycan structures, new tools are needed to study
glycosaminoglycan-protein interactions: specifically, to
examine systematically how the sulfation patterns of HS
direct its interactions with proteins, to identify biologically
active motifs more rapidly, and to look globally across
protein families and glycosaminoglycan classes to under-
stand the role of specific interactions in physiological
processes.
Recently, we and others have developed carbohydrate
microarrays for the high-throughput analysis of carbohy-
drate-protein interactions [18–31]. The miniature array for-
mat permits detection of multiple binding events simulta-
neously and requires minimal amounts of carbohydrate08, February 2007 ª2007 Elsevier Ltd All rights reserved 195
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Glycosaminoglycan Microarraysand protein. Several systems have been used to profile
a wide range of carbohydrate-binding proteins, including
growth factors and cytokines [22–25, 30], lectins [24, 26,
28], antibodies [20, 27], and cell receptors [21, 24]. In
a few cases, microarrays of chondroitin sulfate (CS) and
HS oligosaccharides have been demonstrated to be
powerful tools for studying the binding of proteins to
specific sulfation sequences [22, 23, 25].
Here, we report a facile, microarray-based approach
that enables rapid interrogation of any protein of interest
for binding to various glycosaminoglycan sulfation pat-
terns and classes. The key structural determinants re-
sponsible for protein binding, such as sulfate groups
that participate in the interaction, are elucidated. More-
over, sulfation specificities can be readily compared
across large families or functional classes of proteins. As
the approach is amenable to all glycosaminoglycan sub-
types, direct comparisons of HS, CS, keratan sulfate
(KS), and other classes are possible, providing a more
comprehensive understanding of the specificity of pro-
teins for various glycosaminoglycans. In this study, we
validate the approach by showing that members of the
FGF family have distinct sulfation preferences, consistent
with earlier structural and biochemical studies, and we
further extend those findings by identifying the sulfation
requirements for two previously uncharacterized mem-
bers, FGF16 and FGF17. In addition, we illustrate the
power of glycosaminoglycan microarrays to rapidly pro-
vide new information regarding the interactions and func-
tions of HS by demonstrating that HS interacts with a
number of axon guidance proteins such as slit, netrin,
ephrin, and semaphorin. Sulfation of HS is shown to mod-
ulate the specificity of those interactions and may provide
a means to fine tune the localization and activity of chemo-
tactic proteins during neuronal development.
RESULTS AND DISCUSSION
Development of Glycosaminoglycan Microarrays
In designing the microarrays, we sought to develop
a rapid, convenient approach that would not require spe-
cialized expertise in carbohydrate or surface chemistry.
As such, we chose a flexible, noncovalent strategy for at-
tachment of glycosaminoglycans to poly-L-lysine (PLL)-
coated slides. CS oligosaccharides have previously
been immobilized noncovalently on nitrocellulose mem-
branes, but the approach required synthesis of a neogly-
colipid conjugate for each oligosaccharide [27]. We
wanted to circumvent these derivatization steps and ex-
ploit the high-throughput robotic printing and fluores-
cence scanning technology used for microarrays. Based
on strong precedent with other charged glycans [30, 31]
and DNA [32, 33], we reasoned that anionic glycosamino-
glycans might adhere to PLL-coated slides while main-
taining the ability to interact with proteins.
To validate the approach, we first examined whether
polysaccharides of differing sulfation patterns adhere
uniformly to PLL-coated surfaces. Heparin polysaccha-
rides (MW of 13,000) varying in the number and196 Chemistry & Biology 14, 195–208, February 2007 ª2007 Elposition of sulfate groups were labeled at the reducing
end with 5-(((2-(carbohydrazino)methyl)-thio)acetyl)ami-
nofluorescein in the presence of sodium cyanoborohy-
dride. Specifically, we used polysaccharides that had
been chemically desulfated at key positions: 2-O-desul-
fated heparin in which the 2-O-sulfate groups of uronic
acid had been removed (2-deO), 6-O-desulfated heparin
wherein the 6-O-sulfate groups of glucosamine had
been removed (6-deO), fullyN-acetylated heparin in which
the amino groups of glucosamine were desulfated and N-
acetylated (N-Ac), and fully O-desulfated heparin (deO)
(Figure 1). These naturally derived polysaccharides were
chosen because previous studies have exploited such
preparations to understand glycosaminoglycan-protein
interactions [12, 34–36]. Moreover, the use of HS isolated
from natural sources would enable profiling of protein-
binding patterns to glycosaminoglycans in different cell
types, organs, or developmental stages. Equal concentra-
tions of the polysaccharide-fluorescein conjugates were
manually spotted onto PLL slides, and after washing
with 0.5 M NaCl and PBS, the fluorescence intensity at
530 nm was measured relative to an unconjugated fluo-
rescein control. Importantly, we found that the derivatives
adhered uniformly to the slide surface irrespective of the
sulfation pattern (Figure 2A). Approximately 86% of
the polysaccharide attached to the surface in each case,
indicating efficient and uniform immobilization of the
polysaccharides. Attachment of the carbohydrate was
stable to high salt concentrations and was observed to
be linear with respect to polysaccharide concentration
(Figure 2B).
Having shown uniform, efficient attachment of various
polysaccharides to PLL-coated surfaces, we examined
whether these surfaces could be exploited to detect gly-
cosaminoglycan-protein interactions. A Microgrid II ar-
rayer robot was used to deliver nanoliter volumes of hep-
arin (unconjugated to fluorescein) in solutions ranging in
concentration from 5 nM to 1000 nM, yielding spots that
were 100 mm in diameter. The microarray was incubated
with FGF2, a member of a large family of growth factors in-
volved in cell proliferation, development, and tumor angio-
genesis and one of the best characterized HS-binding
proteins [4, 37]. Binding of FGF2 was subsequently de-
tected by incubation of the array with an anti-FGF2 anti-
body followed by a secondary Cy3-labeled antibody. We
found that FGF2 bound to heparin on the array in a concen-
tration-dependent manner (Figures 3A and 3B). Binding of
FGF2 to as little as 0.01–10 fmol heparin could be de-
tected on the microarray, indicating very high detection
sensitivity. Interestingly, the S-shaped kinetic curve im-
plied a complex binding mechanism consistent with coop-
erative binding of FGF2 to the polysaccharide. Analysis of
the Hill plot gave a Hill coefficient of 6.1, suggestive of
positive cooperativity. These results are similar to those
of previous studies suggesting a multisite binding model
for HS-protein interactions and/or the possibility of co-
operative binding sites [6, 38–40]. Nonlinear regression
analysis of the relative fluorescence intensity as a function
of carbohydrate concentration afforded an EC50 value ofsevier Ltd All rights reserved
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Glycosaminoglycan MicroarraysFigure 1. Heparin Polysaccharides Used
for the Analysis of HS-Protein Interac-
tions
For simplicity, the uronic acid residues are
depicted as iduronic acid. n = 20–22.80.2 ± 2.7 nM, similar to Kd values determined for the bind-
ing of FGF2 to both heparin polysaccharides and oligo-
saccharides by surface plasmon resonance and optical
biosensor binding assays [15, 41].
To determine whether the approach could be exploited
to rapidly probe the sulfation specificities of proteins,
we constructed a high-density microarray containing dif-
ferentially sulfated HS derivatives. Specifically, heparin,
2-O-desulfated heparin, 6-O-desulfated heparin, fully N-
acetylated heparin, and fully O-desulfated heparin were
printed on a 1 cm 3 1 cm grid (480 spots) at concentra-
tions ranging from 5 nM to 100 mM. We found that FGF2
displayed distinct binding preferences for each sulfated
form. Shown in Figure 3C is the relative binding of FGF2
to the HS variants at three different carbohydrate concen-
trations. By printing the polysaccharides over a wide con-
centration range, those concentrations that lie in a nearly
linear part of the binding curve can be established, which
enables comparison of the relative binding affinities of
a protein to each sulfated variant. Strong binding of
FGF2 to heparin and 6-O-desulfated heparin was ob-
served, whereas the interaction was significantly reduced
upon 2-O-desulfation, N-desulfation and acetylation, or
complete O-desulfation of heparin. These findings agree
with other biochemical studies, in which 2-O-sulfation,
but not 6-O-sulfation, was shown to be crucial for the hep-
arin-FGF2 interaction. Moreover, the results are reinforced
by X-ray crystallographic studies demonstrating that the
2-O-sulfate and N-sulfate groups of heparin engage inChemistry & Biology 14, 195–2electrostatic interactions with basic residues of FGF2
[42–44].
Quantitative analysis of the relative fluorescence
intensities as a function of carbohydrate concentration
afforded an EC50 value for 6-O-desulfated heparin of
83.3 ± 1.3 nM, comparable to that of heparin (Figure 3D).
In contrast, removal of the 2-O-sulfate and N-sulfate
groups significantly reduced the affinity of FGF2 for hepa-
rin (EC50 = 685.7 ± 17.0 and 666.4 ± 10.1 nM, respec-
tively). As expected, no appreciable binding of FGF2 to
completely O-desulfated heparin was observed. Although
we obtained excellent quantitative data for FGF2, we note
that some proteins are more amenable to this analysis
than others. Importantly, all proteins that we examined
showed linear binding to glycosaminoglycans within
a given concentration range, which enabled direct com-
parison of the relative binding affinity of proteins for the
different HS variants. Together, these results highlight
the power of microarrays to enable rapid, systematic
explorations into the importance of sulfation.
Sulfation Specificities Across the Fibroblast
Growth Factor Family
The ability to analyze many glycosaminoglycan-protein in-
teractions simultaneously facilitates comparisons across
large protein families. Previous studies have suggested
that different FGF members recognize distinct HS sulfa-
tion sequences, raising the interesting possibility that the
sulfation patterns presented on the cell surface may help08, February 2007 ª2007 Elsevier Ltd All rights reserved 197
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Glycosaminoglycan Microarraysto activate particular FGF-signaling pathways [43, 45, 46].
We examined the sulfation specificities of various mem-
bers of the family, including FGF1, FGF4, FGF16, and
FGF17. Notably, each family member exhibited a distinct
sulfation preference (Figure 4). In contrast to FGF2, FGF1
showed a strong reduction in binding to 6-O-desulfated
heparin relative to heparin and a more modest reduction
in binding to 2-O-desulfated heparin. On the other hand,
Figure 2. Heparin Polysaccharides Adhere Uniformly and
Efficiently to Poly-L-Lysine-Coated Slides Independent of
Sulfation Pattern
(A) Fluorescein-labeled heparin derivatives of varying sulfation
patterns (1 pmol) were manually spotted onto PLL-coated slides. The
fluorescence intensity was measured relative to an unconjugated
fluorescein control.
(B) Fluorescein-conjugated heparin binds to PLL-coated slides in a
linear, concentration-dependent manner.
Error bars represent the standard error of the mean (SEM) from four
experiments.198 Chemistry & Biology 14, 195–208, February 2007 ª2007 Els2-O-desulfation and 6-O-desulfation led to a comparable
reduction in FGF4 binding to heparin, suggesting that sul-
fation at both positions is equally important. In all cases,
N-sulfation was found to be a critical determinant for bind-
ing. Our results are supported by previous studies indicat-
ing that FGF1 requires 6-O-sulfation and N-sulfation, but
not 2-O-sulfation, for heparin binding [7, 47], whereas
FGF4 requires sulfation of both the 2-O- and 6-O-posi-
tions [45].
We also characterized two new members of the FGF
family, FGF16 and FGF17, whose sulfation specificities,
to our knowledge, were unknown. FGF16 plays a role in
the development of the heart [48], whereas FGF17 partic-
ipates in the induction and patterning of the developing
brain [49]. We found that FGF16 required sulfation at the
2-O-, 6-O-, and N-positions at low polysaccharide con-
centrations. Interestingly, at higher concentrations, bind-
ing of FGF16 to 6-O-desulfated heparin was observed,
suggesting a greater importance for the 2-O-sulfate-posi-
tion. With FGF17, we identified 6-O-sulfation and N-sulfa-
tion as key determinants for heparin binding. While 2-O-
desulfation of heparin diminished the interaction, the
loss of binding was less than that observed upon 6-O-
desulfation, suggesting a greater role for 6-O-sulfation.
These findings demonstrate that the FGF family mem-
bers exhibit distinct preferences for HS sulfation motifs,
and they highlight the ease with which the sulfation spec-
ificities of HS-binding proteins can be elucidated by using
microarrays. The enhanced affinity of FGF family mem-
bers for particular sulfation motifs may be important
during development, as the sulfotransferases involved in
HS biosynthesis are differentially expressed in certain tis-
sues and developmental stages [50, 51]. For instance,
studies have shown that alternations in the HS sulfation
pattern that favor FGF1 binding relative to FGF2, as well
as changes in growth factor production from FGF2 to
FGF1, occur as neural precursor cells cease to proliferate
and begin to differentiate [50, 52, 53]. It will be interesting
to examine whether the sulfation motifs uncovered by our
microarrays for FGF16 and FGF17 are upregulated during
organogenesis or brain development and modulate the
activity of these important growth factors.
Sulfation Specificities of Axon Guidance Proteins
Glycosaminoglycan microarrays can also be exploited to
study proteins that lack homology, but share a common
function, in order to probe the involvement of HS in spe-
cific biological processes. For instance, previous studies
have shown that HS interacts with slit2, a protein that di-
rects axons toward specific targets in the developing brain
[16, 54, 55]. However, the importance of sulfation in direct-
ing this interaction has not been examined. We also
sought to investigate whether HS might interact with a
variety of chemotactic proteins and thus participate
more broadly in axon guidance.
We found that slit2 bound to heparin on the microarray,
consistent with cellular studies in which 125I-labeled slit in-
teracted with the surface of HS-expressing cells and re-
cent SPR studies with HS oligosaccharides (Figure 5A)evier Ltd All rights reserved
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Glycosaminoglycan MicroarraysFigure 3. FGF2 Interacts with Heparin Polysaccharides on the Microarray and Favors Binding to Heparin and 6-O-Desulfated
Heparin
(A) Representative image of a portion of the microarray. Multiple concentrations of heparin and heparin derivatives were spotted onto the microarray
to create a pattern of 480 spots. The panel on the right indicates the corresponding polysaccharides and their concentrations (given in nM).
(B) Nonlinear regression analysis of the relative fluorescence intensity as a function of heparin concentration.
(C) Relative binding of FGF2 to various sulfated forms of heparin. The relative fluorescence intensities were normalized with respect to the highest
observed fluorescence intensity on the array and were plotted at polysaccharide concentrations of 600, 650, and 700 nM, which lie in the linear
part of the binding curve for 2-O-desulfated and N-acetylated heparin.
(D) Nonlinear regression analysis for the different sulfated variants. The relative fluorescence intensities were normalized with respect to the highest
fluorescence intensity for each variant.
Error bars represent the SEM from four experiments.Chemistry & Biology 14, 195–208, February 2007 ª2007 Elsevier Ltd All rights reserved 199
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Glycosaminoglycan MicroarraysFigure 4. Comparison of the Sulfation Specificities of FGF Family Members
(A–D) Binding of (A) FGF1, (B) FGF4, (C) FGF16, and (D) FGF17 to the microarrays. The relative fluorescence intensities were plotted at polysaccharide
concentrations of 10, 25, and 50 mM, which lie in the linear part of their binding curves. Error bars represent the SEM from four experiments.[16, 54]. More importantly, we observed a strong prefer-
ence of slit2 for 6-O-sulfated heparin, as indicated by a
significant decrease in slit2 binding upon desulfation at
the 6-position. By comparison, 2-O-desulfation elicited
a weaker response. Slit2 also bound N-acetylated heparin
poorly, indicating an important role for N-sulfation in bind-
ing. These results establish that slit2 has a preference
for HS sulfation sequences that contain 6-O-sulfation
and N-sulfation.
As independent confirmation of the microarray data, we
examined the effects of HS sulfation on slit-mediated
axon guidance. Olfactory bulb explants isolated from
embryonic day 14.5 embryos were cocultured with slit2-
expressing HEK293 cell aggregates in a collagen-Matrigel
matrix. To visualize the axons, the cultures were stained
with an anti-tau antibody and were examined by confocal
fluorescence microscopy. As shown in Figure 6A, the se-
creted slit2 protein repels growing axons from the olfac-
tory bulb. Previous studies have established that slit2
requires HS to mediate axon repulsion, as treatment
of the cultures with heparinase or exogeneous HS abol-
ished the repulsive activity of slit2 [54]. We therefore inves-200 Chemistry & Biology 14, 195–208, February 2007 ª2007 Elstigated the effects of the sulfated HS variants employed
in our microarrays. The number of fasciculated axon bun-
dles in the proximal and distal quadrants of the coculture
was measured for each sulfated variant (Figure 6A). As
expected, slit2 induced axonal repulsion, as indicated
by the low proximal to distal ratio observed. We found
that heparin and 2-O-desulfated heparin abolished the
repulsive effects of slit2. In contrast, 6-O-desulfated and
N-acetylated heparin had only modest effects on slit2-
induced axonal repulsion, and completely O-desulfated
heparin had no effect. These findings are consistent with
the results obtained from our microarray analyses, which
indicate that only heparin and 2-O-desulfated heparin
interact strongly with slit2.
We next examined whether HS sulfation patterns are
important for neuronal cell migration mediated by slit2.
HEK293 cell aggregates expressing slit2 were cocultured
with anterior subventricular zone (SVZa) explants from
postnatal day 4–7 rats in a collagen-Matrigel matrix. Mi-
grating neurons were visualized by transmitted light
microscopy by using an inverted Zeiss microscope at
53 magnification. As shown in Figure 6B, slit2 repelledevier Ltd All rights reserved
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Glycosaminoglycan MicroarraysFigure 5. A Variety of Chemotactic Proteins Bind to Heparin/HS in a Sulfation-Dependent Manner
(A–E) Binding of (A) slit2, (B) netrin1, (C) sema5B, (D) ephrinA1, and (E) ephrinA5 to the microarrays. The relative fluorescence intensities were plotted
at polysaccharide concentrations that lie in the linear part of their respective binding curves. Error bars represent the SEM from four experiments.the migration of cells from the explants. Notably, the addi-
tion of heparin or 2-O-desulfated heparin to the medium
abolished the repulsive activity of slit2 on neuronal migra-
tion. To quantify these effects, the ratio of the number of
migrating neurons in the proximal versus the distal quad-
rants of the coculture was plotted (Figure 6B). The repul-
sion induced by slit2 can be seen by the presence of
more neurons on the distal than the proximal side of theChemistry & Biology 14, 195–2explant. In contrast, the addition of heparin or 2-O-desul-
fated heparin caused a more symmetrical, radial pattern of
cells, in which equal numbers of neurons were found on
both sides. Consistent with our microarray data, 6-O-
desulfated heparin had only a slight effect on neuronal
repulsion, and neither N-acetylated heparin nor com-
pletely de-O-sulfated heparin had an effect relative to
the control (Figure 6B and data not shown). Together,08, February 2007 ª2007 Elsevier Ltd All rights reserved 201
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Glycosaminoglycan MicroarraysFigure 6. Slit2-Mediated Axon Guidance and Neuronal Migration Are Modulated by Specific HS Sulfation Patterns
(A) HEK293 cells expressing secreted slit2 were cocultured with embryonic day 14.5 rat olfactory bulbs in a 2:2:1 collagen:Matrigel:DMEM matrix in
the presence of the indicated polysaccharides (30 mM). The cultures were immunostained with an anti-tau antibody and imaged by using confocal
fluorescence microscopy. The number of fasciculated axon bundles in the proximal and distal quadrants of the coculture was measured for each
polysaccharide variant. Error bars represent the SEM from three experiments. The scale bars indicate 500 mm.
(B) HEK293 cells expressing secreted slit2 were cocultured with postnatal day 3–6 rat SVZa explants in a 2:2:1 collagen:Matrigel:DMEM matrix in the
presence of the indicated polysaccharides (30 mM). The migration of cells from the explant was visualized with confocal bright-field microscopy.
N-acetylated and fully O-desulfated heparin had no effect on slit-mediated axon repulsion. The ratio of migrating neurons in the proximal versus distal
quadrants was quantified relative to the explant. Error bars represent the SEM from three experiments. The scale bars indicate 500 mm.these functional studies corroborate our microarray anal-
yses and demonstrate that glycosaminoglycan microar-
rays can be used to gain new insights into the biological
activities of HS-binding proteins.
To examine whether HS participates more broadly in
axon guidance processes, we probed a panel of chemoat-
tractant/chemorepellent proteins, including netrin1,
ephrinA1, ephrinA5, and semaphorin5B (sema5B). Netrin
functions as a chemoattractant on commissural axons
when binding to its receptor DCC (deleted in colorectal
cancer), whereas the ephrin family of proteins has been
shown to regulate axon guidance through contact-medi-
ated repulsion, inducing collapse of neuronal growth
cones during development [55, 56]. The semaphorins
are a large family of conserved secreted proteins that me-
diate chemotactic guidance events such as collapse of
motor neuron growth cones and repulsion of growing
axons [57]. Interestingly, semaphorin5A (sema5A) has
been shown to interact with both HS and CS glycosamino-
glycans [58]. Using the microarrays, we found that loss of
2-O-sulfation, 6-O-sulfation, or N-sulfation reduced the
binding of netrin1 to heparin by approximately the same
extent (Figure 5B). Complete O-desulfation nearly abol-202 Chemistry & Biology 14, 195–208, February 2007 ª2007 Elseished netrin1 binding, particularly at lower concentrations
of polysaccharide. These data suggest that netrin1
requires sulfation at the 2-O-, 6-O-, and N-positions,
although we cannot exclude the possibility that netrin
does not require a specific sulfation sequence for heparin
binding. Either way, these findings are interesting, as the
chemorepellent and chemoattractant proteins, slit and
netrin, respectively, clearly interact with HS in a distinct
manner. Remarkably, HS appears to be essential for the
axon guidance activities of both netrin and slit. We found
that netrin-mediated attraction was greatly diminished
heparinase treatment or the addition of exogenous hepa-
rin to netrin1-olfactory bulb cocultures (see Figure S1 in
the Supplemental Data available with this article online).
Sema5B exhibited a preference for specific sulfation
motifs, as 2-O-desulfation and N-desulfation/acetylation
of heparin reduced binding of sema5B by 50%, whereas
6-O-desulfation had a lesser effect (Figure 5C). Moreover,
to our knowledge, we demonstrate for the first time that
ephrinA1 and ephrinA5 interact with HS and have a prefer-
ence for both 2-O- and N-sulfation (Figures 5D and 5E).
Thus, their binding profile more closely resembles that of
sema5B and contrasts with that of slit2. EphrinA1 andvier Ltd All rights reserved
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Glycosaminoglycan MicroarraysephrinA5 share 68% homology, which likely accounts for
their similar sulfation specificity. The ability of the ephrins
to elicit a variety of biological responses is believed to
arise from their promiscuous binding pattern (all ephrin
A1–A5 ligands bind to all A1–A10 ephrin receptors) and
the formation of higher-order ligand-receptor complexes
[56, 59]. One possibility is that the specificity and multiva-
lency of the ephrin/ephrin receptor interaction may be
modulated by interactions with HS. Although this hypoth-
esis remains to be tested, an intriguing observation is
that ephrin null mutants in C. elegans enhance the pheno-
type of sulfotransferase null mutants, which suggests a
possible functional connection between ephrin and HS
sulfation [60].
It has become increasingly evident that HS plays an im-
portant role in axon targeting in the developing nervous
system. For instance, mice lacking the HS-modifying en-
zyme N-acetylglucosamine N-deacetylase/N-sulfotrans-
ferase (Ndst1) exhibit severe developmental defects of
the forebrain, including cerebral hypoplasia and lack of ol-
factory bulbs [61]. Studies of the Xenopus optic pathway
indicate that inhibiting 2-O- and 6-O-sulfation causes de-
veloping axons to bypass their target, the tectum [62]. Fur-
thermore, neuronal guidance defects such as incorrect
midline patterning were observed in genetic studies of
C. elegans mutants lacking certain sulfotransferases
[63]. These studies suggest that the sulfation patterns of
HS are critical for correct axon targeting. Our discovery
of the unique affinities of axon guidance proteins for dis-
parate HS sulfation patterns substantiates these previous
studies. An intriguing possibility is that HS may participate
in controlling the localization and activity of chemotactic
proteins during neuronal development, possibly assisting
in the creation of local protein gradients and facilitating in-
teractions with cell surface receptors.
The variety of sulfation specificities observed by these
proteins, coupled with other studies linking particular sul-
fotransferases to axon targeting [60–63], underscores the
importance of elucidating the sulfation specificities of
axon guidance proteins. Given the large number of poten-
tial sulfation sequences, the creation of focused libraries
of synthetic oligosaccharides with defined sulfation motifs
will be important in future studies. The microarrays de-
scribed herein should help in this regard by allowing gly-
cosaminoglycan-protein interactions to be probed rapidly
and by providing valuable information to guide oligosac-
charide library designs.
Comparisons Across Glycosaminoglycan Classes
In addition to versatility with respect to proteins, our mi-
croarray platform is compatible with all glycosaminogly-
can subtypes, which permits systematic comparisons of
protein binding across various classes. Such compari-
sons are important for understanding the specificities of
glycosaminoglycan-binding proteins in vivo, where vari-
ous subtypes may compete with one another for protein
binding. We constructed microarrays containing heparin;
HS; CS enriched in the CS-A, CS-C, CS-D, or CS-E sulfa-
tion motifs; dermatan sulfate (CS-B); KS; and hyaluronicChemistry & Biology 14, 195–acid (HA). The binding of FGF1 and FGF2 to the array
was initially tested because previous studies have demon-
strated that FGF1 interacts with HS, but not CS polysac-
charides, whereas FGF2 recognizes both heparin and
CS-E polysaccharides with similar binding affinity [64].
As expected, we found that FGF1 bound strongly to HS
and heparin on the microarray and interacted only weakly
with CS-E and other glycosaminoglycan classes (Figure 7).
In contrast, FGF2 interacted with HS, heparin, and CS-E to
a comparable extent. As further validation, we demon-
strated that HA-binding protein (HABP) binds selectively
to HA on the microarray.
The ability of various axon guidance proteins to interact
with these glycosaminoglycan classes was next exam-
ined. Interestingly, all of the proteins recognized heparin,
HS, and CS polysaccharides enriched in the CS-E motif
(Figures 7D–7H). Little or no binding of the proteins to
other glycosaminoglycans such as KS or HA was de-
tected. In the case of ephrinA1, ephrinA5, and sema5B,
weak binding to other CS polysaccharides and dermatan
sulfate was observed, although the extent of binding was
generally lower than that of heparin, HS, and CS-E. Nota-
bly, all of the proteins interacted weakly with polysaccha-
rides enriched in the CS-D motif, despite the fact that
CS-D and CS-E have the same number of sulfate groups
per disaccharide unit. Thus, it appears that the precise
placement of the sulfate groups, rather than nonspecific
electrostatic effects, governs the binding of proteins to
CS. Indeed, we have found previously that defined tetra-
saccharides displaying two sequential CS-E sequences
interact specifically with several proteins, including mid-
kine, brain-derived neurotrophic factor (BDNF), and tumor
necrosis factor-a (TNF-a) [22, 23]. Lastly, we validated our
microarray results further by showing that CS-E polysac-
charides abolish slit2-mediated repulsion of both axons
and migrating neurons to the same extent as heparin
(see Figures S2 and S3). Together, our studies suggest
that CS-E and HS may modulate the activity of axon guid-
ance proteins in vivo. In accordance with this hypothesis,
it has recently been reported that sema5A attracts axons
of the diencephalon in the presence of HS, but becomes
repulsive toward the same axons when CS is present
[58]. Interestingly, sema5B also appears to possess this
dual ability to interact with both HS and CS glycosamino-
glycans. Future studies will address the intriguing func-
tional interplay between CS-E and HS.
SIGNIFICANCE
Despite growing recognition of the importance of gly-
cosaminoglycans in many physiological processes,
a detailed understanding of their structure-activity
relationships has been lacking. Here, we report a fac-
ile, microarray-based platform that enables rapid
interrogation of glycosaminoglycan-protein interac-
tions without requiring specialized expertise in carbo-
hydrate or surface chemistry. The key structural deter-
minants responsible for protein binding, such as
sulfate groups that participate in the interaction, are208, February 2007 ª2007 Elsevier Ltd All rights reserved 203
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(A–H) Binding of (A) FGF1, (B) FGF2, (C) hyaluronic acid-binding protein, (D) slit2, (E) netrin1, (F) sema5B, (G) ephrinA1, and (H) ephrinA5 to heparan
sulfate (HS), heparin (Hep), chondroitin sulfate-A (CS-A), dermatan sulfate (CS-B), chondroitin sulfate-C (CS-C), chondroitin sulfate-D (CS-D), chon-
droitin sulfate-E (CS-E), keratan sulfate (KS), and hyaluronic acid (HA). The microarrays were constructed from polysaccharide solutions that ranged in
concentration from 5 nM to 25 mM. The relative fluorescence intensities were plotted at polysaccharide concentrations of 5, 10, and 20 mM, which lie in
the linear region of the binding curves. Error bars represent the SEM from four experiments.elucidated. Specificities can be compared across
protein families or functional classes, and direct com-
parisons of HS, CS, and other glycosaminoglycans are
possible, providing a more comprehensive under-
standing of protein specificity. We anticipate that the
technologywill enable profiling of protein-binding pat-
terns to glycosaminoglycans isolated from different
cell types, organs, or cell states. To illustrate the ap-204 Chemistry & Biology 14, 195–208, February 2007 ª2007 Elproach, we demonstrated that FGF family members
recognize distinct sulfation motifs. Moreover, we dis-
covered several HS-binding proteins, including FGF17,
ephrinA5, andephrinA6.Wealso found thatHSbinds to
several classes of chemotactic proteins, and we show
that HS is required for netrin-mediated axonal attrac-
tion. Furthermore, we compared the interactions of
theseproteinswithvariousglycosaminoglycanclassessevier Ltd All rights reserved
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Glycosaminoglycan Microarraysand found that many proteins that recognize HS also
recognize CS-E. This suggests that numerous HS-
binding proteins may be subject to regulation by both
HS and CS glycosaminoglycans.
An important goal for the future will be to under-
stand the sulfation specificities in greater detail. Given
the large number of potential sequences, the creation
of focused libraries of synthetic oligosaccharides con-
taining a limited set of sulfation motifs will be essen-
tial. The microarrays described here will help define
the specificities of proteins and guide synthetic library
designs. The ability to discover new glycosaminogly-
can-binding proteins and elucidate their specificities
promises to accelerate the identification of glycos-
aminoglycan-binding proteins and provide a broader
understanding of their physiological roles.
EXPERIMENTAL PROCEDURES
Materials
Heparin polysaccharides were purchased from Neoparin (Alameda,
CA). The uronic acid composition of heparin and its sulfated deriva-
tives was 75% L-iduronic acid and 25% D-glucuronic acid, as stated
by the manufacturer. CS-A, CS-C, CS-D, CS-E, and KS polysaccha-
rides were purchased from Seikagaku America (Fallmouth, MA).
CS-B and HA were purchased from Sigma-Aldrich (St. Louis, MO). Hu-
man FGF1, FGF2, FGF4, FGF16, FGF17, ephrinA5, mouse ephrinA1,
chicken netrin1, and their respective antibodies were purchased
from R&D Systems (Minneapolis, MN). Hyaluronic acid-binding protein
and its corresponding antibody were purchased from U.S. Biologicals
(Swampscott, MA). (5-(((2-(carbohydrazino)methyl)-thio)acetyl)amino-
fluorescein was purchased from Invitrogen (Carlsbad, CA). Myc-
tagged human slit2- and HA-tagged chicken netrin1-expressing
HEK293 cells were a gift from Professor Yi Rao (Northwestern Univer-
sity; Chicago, IL) [65, 66]. HEK293 cells expressing c-myc-tagged hu-
man slit2 were grown in 100 mm dishes for 3 days and were extracted
with 5 ml of 1 M NaCl in the presence of a cocktail of protease inhibitors
(Roche Diagnostics; Indianapolis, IN) as previously reported [54]. The
extract was then concentrated, and the buffer was exchanged for
PBS (137 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl [pH 7.4]) by using
Centricon filters (30,000 MWCO; Millipore; Billerica, MA). Fc-tagged
human AP-Sema5B[TSR1-4]-Fc was a generous gift from Professor
Alex Kolodkin (Johns Hopkins University; Baltimore, MD). The AP-
Sema5B[TSR1-4] construct was transfected into HEK293 cells and
was grown in 100 mm dishes for 2–4 days. The culture media (100 ml)
containing 5 nM of the secreted sema5B protein was collected,
centrifuged for 30 min at 15,0003 g, concentrated to 1–2 mM with Cen-
tricon filters (10,000 MWCO), and dialyzed into PBS. The PLL-coated
glass slides were purchased from Erie Scientific (Portsmouth, NH).
Timed-pregnant Sprague Dawley rats were purchased from Charles
River Laboratories (Wilmington, MA). All handling and experimental
procedures with animals were approved by the Institutional Animal
Care and Use Committee at Caltech and were performed in accor-
dance with the Public Health Service Policy on Humane Care and
Use of Laboratory Animals.
Heparin-Fluorophore Labeling and Surface Adherence Studies
Five molar excess of 5-(((2-(carbohydrazino)methyl)-thio)acetyl)amino-
fluorescein was incubated with heparin, 2-O-desulfated heparin, 6-O-
desulfated heparin, fully O-desulfated heparin, N-desulfated/N-acety-
lated heparin in 0.2 M borate buffer (pH 8.0) and 100 mM NaCl at 37C
for 48 hr. The conjugated heparin derivatives were then dialyzed in H2O
to remove any unreacted fluorophore. For the fluorescein control mol-
ecule, 2 mmol 5-(((2-(carbohydrazino)methyl)-thio)acetyl)aminofluores-
cein was reacted with acetaldehyde (1.5 equivalents) in DMF:H2OChemistry & Biology 14, 195–(1:1; 200 ml) at room temperature for 24 hr and was subsequently
purified by using a 1 ml C18 Sep-Pak column. Fractions (1 ml) were col-
lected by using an increasing gradient of acetonitrile in water (0%–
90%). The product eluted at85% acetonitrile. The fraction containing
the product was confirmed by mass spectrometry. The concentrations
of the compounds were adjusted to 1 mM by using the extinction coef-
ficient of the fluorophore (3 = 70,000 M1cm1) at 518 nm. The com-
pounds (1 ml) were then manually spotted onto PLL-coated slides in
quadruplicate and were dried in a 70% humidity chamber overnight.
The resulting microarrays were analyzed for fluorescence signal inten-
sity and spot morphology by using a GenePix 5000a scanner and were
placed in a dust-free chamber overnight. The slides were then washed
with 0.5 M aqueous NaCl for 30 min with gentle rocking, followed by
PBS (5 3 10 min), dried under a gentle stream of N2. Signal intensities
were then recorded. Comparison of signal intensities before and after
washing yielded the same extent of adherence of the polysaccharides
to the microarray, 86% based on the extinction coefficient of the
fluorophore.
Generation of Microarrays
The relative concentrations of heparin, HS, CS, and KS polysaccha-
rides were calibrated to one another by using the carbazole assay for
uronic acid residues [67]. Briefly, the acid borate reagent (1.5 ml of a
solution of 0.80 g sodium tetraborate in 16.6 ml H2O and 83.3 ml sulfuric
acid) was added to 20 ml glass vials with teflon caps. The polysaccha-
rides (50 ml of a 4 mg/ml stock in H2O) were added, and the solutions
were placed in a boiling water bath for 10 min. After cooling and the ad-
dition of the carbazole reagent (50 ml of 0.1% w/v carbazole in 100%
ethanol), the solutions were boiled for 15 min. The absorbance was
measured at 530 nm and compared to a D-glucuronolactone standard
in H2O. Solutions of the polysaccharides (10 ml well
1 in a 384-well
plate) were spotted onto PLL-coated slides by using a Microgrid II
arrayer (Biorobotics; Cambridge, UK) at room temperature and 50%
humidity. Solution concentrations ranged from 5 nM to 100 mM, and
the arrayer printed 1 nl of each concentration eight times. The resulting
arrays were incubated in a 70% humidity chamber at room temperature
overnight and then stored in a low-humidity, dust-free dessicator.
Protein-Binding Analyses
The slides were blocked with 3% bovine serum albumin (BSA) in PBS
(5 ml) with gentle rocking at 37C for 1 hr. These conditions were em-
pirically determined to reduce nonspecific binding of proteins to the
microarray and to provide optimal signal to noise ratios (an average
of 10:1). A 2 cm box was drawn around the polysaccharide spots
with a hydrophobic slide marker (Super Pap Pen, Research Products
International Corp.; Mount Prospect, IL) prior to blocking. Human
FGF1, FGF2, FGF4, FGF16, FGF17, ephrinA1, slit2, sema5B, hyalur-
onic acid-binding protein, mouse ephrinA5, or chicken netrin1 was
reconstituted in 1% BSA in PBS, added to the slides in 50 ml quantities
at a concentration of 1–2 mM, and incubated in a humidity chamber
(empty pipette tip box containing 10 ml brine in the bottom) for 1 hr
at room temperature. The slides were then washed five times for
3 min each in PBS (5 ml) while gently rocking. After the washes, the
slides were incubated with 5 ml of the appropriate primary antibody
in 1% BSA in PBS solution with gentle rocking for 1 hr. Optimal con-
centrations were determined for each antibody (1:500 for anti-FGF1;
1:1000 for anti-FGF2, anti-FGF4, anti-FGF16, anti-netrin1, and anti-
myc [slit2]; 1:2000 for anti-FGF17). The slides were then washed five
times for 3 min each in PBS (5 ml) while gently rocking. Next, the slides
were incubated with 5 ml of a secondary IgG antibody conjugated to
either Cy3 or Cy5 in the dark with gentle rocking for 1 hr (1:5000, Mo-
lecular Probes), washed with PBS followed by H2O, and then dried
under a gentle stream of N2. A human IgG antibody conjugated to
Cy3 was used for Fc-tagged ephrinA1, ephrinA5, and sema5B
(1:5000, Molecular Probes). All incubations and washes were carried
out at room temperature unless otherwise noted. The microarrays
were analyzed at 532 nm for Cy3 or 635 nm for Cy5 by using a GenePix
5000a scanner, and fluorescence quantification was performed by208, February 2007 ª2007 Elsevier Ltd All rights reserved 205
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signal anisotropy is a common occurrence at low concentrations in
carbohydrate microarrays [25, 29]. To ensure accurate signal quantifi-
cation, the average signal intensity was calculated over a fixed area for
all spots. No fluorescence intensity was observed with controls per-
formed with primary and secondary antibodies alone. Results were
plotted with Kaleidagraph 6.0 software. Each protein was analyzed
in triplicate, and the data represent an average of 5–8 spots for a given
carbohydrate concentration.
Dissociation Constant Measurements
The EC50 values for binding of FGF2 to the various heparin/HS forms
were calculated from nonlinear regression analysis of the relative
fluorescence intensity as a function of carbohydrate concentration.
Cooperative binding of FGF2 to HS polysaccharides on the microarray
surface was observed, consistent with the Hill equation:
f =
fmax,½HSn
ECn50 + ½HSn
+ fo; (1)
where f is the observed fluorescence intensity, fmax is the fluorescence
intensity at saturation, fo is the initial fluorescence, [HS] is the carbohy-
drate concentration, and n is the Hill coefficient.
Cell and Tissue Culture
Stable HEK293 cell lines expressing human slit2 or chicken netrin1
were maintained in DMEM supplemented with 10% fetal bovine serum
and antibiotics in a 5% CO2-humidified incubator at 37
C. Cellular ag-
gregates were prepared by the hanging drop method [68]. For the axon
guidance assay, olfactory bulb explants were isolated with a tungsten
needle from timed-pregnant rats at embryonic day 14.5 and were co-
cultured in a 2:2:1 Matrigel:collagen:DMEM mixture with HEK293 ag-
gregates expressing either slit2 or netrin1. In the case of the neuronal
migration assay, SVZa explants were isolated from the rostral migra-
tory stream of postnatal day 4–7 rat olfactory bulbs and were cocul-
tured with HEK293 aggregates expressing slit2 in a 2:2:1 Matrigel:
collagen:DMEM mixture as previously described [69]. CS-E, heparin,
2-O-desulfated heparin, 6-O-desulfated heparin, N-acetylated hepa-
rin, or fully O-desulfated heparin (30 mM) was added to the Matrigel
mixture and media in both the axon guidance and neuronal migration
assays. The cocultures for both assays were incubated at 37C for
48 hr. For the netrin1 axon guidance assay, either 30 mM heparin or
5 U/ml heparinase III (Sigma) was added to the cocultures. Quantifica-
tion was performed by measuring the number of migrating neurons or
fasciculated axon bundles in the proximal versus distal quadrants of
the coculture as described previously [70]. All experiments were
done in triplicate to ensure reproducibility.
Imaging and Immunostaining
The olfactory bulb cocultures were rinsed once with PBS, fixed in 4%
paraformaldehyde for 20 min at room temperature, washed twice with
PBS, permeabilized in 0.3% Triton X-100 for 5 min at room tempera-
ture, and washed twice with PBS. Nonspecific binding was blocked
with 3% BSA for 1 hr at room temperature. The blocking solution
was rinsed off once with PBS. The olfactory bulb cocultures were
then incubated with an anti-tau antibody (rabbit polyclonal, 1:500;
Sigma) in 3% BSA for 2 hr at room temperature. Excess antibody
was washed away five times with PBS. Anti-rabbit IgG Alexa Fluor
488 (1:500; Invitrogen) was added for 1 hr at 37C in 3% BSA. Excess
secondary antibody was washed off five times with PBS. The cocul-
tures were imaged with a Zeiss Axiovert 100M inverted confocal laser
microscope in the Biological Imaging Center in the Beckman Institute
at Caltech. The images were captured with LSM Pascal software by
using 53, 103, or 203 objectives.
Supplemental Data
Supplemental Data include the effects of heparin and CS-E on netrin1-
mediated chemoattraction and slit2-mediated chemorepulsion,206 Chemistry & Biology 14, 195–208, February 2007 ª2007 Erespectively, and are available at http://www.chembiol.com/cgi/
content/full/14/2/195/DC1/.
ACKNOWLEDGMENTS
We thank Dr. J.L. Riechmann, Director of the Millard and Muriel Jacobs
Genetics and Genomics Laboratory at the California Institute of Tech-
nology, for assistance with printing the microarrays, and Dr. S.E. Tully,
C.J. Rogers, and Dr. M.C. Bryan for helpful discussions. We also thank
M. Ward, Professor Y. Rao, and Professor J. Wu for the slit2 and
netrin1 cell lines and for training in neuronal migration and coculture
techniques. We thank Professor A. Kolodkin and R. Matsuoka for the
generous gift of sema5B. This research was supported by a National
Science Foundation Minority Postdoctoral Fellowship (E.L.S.), the
National Institutes of Health (RO1 NS045061), the American Cancer
Society (RSG-05-106-01-CDD), and the Tobacco-Related Disease
Research Program (14RT-0034).
Received: August 30, 2006
Revised: December 13, 2006
Accepted: December 28, 2006
Published: February 23, 2007
REFERENCES
1. Capila, I., and Linhardt, R.J. (2002). Heparin-protein interactions.
Angew. Chem. Int. Ed. Engl. 41, 391–412.
2. Whitelock, J.M., and Iozzo, R.V. (2005). Heparan sulfate: a com-
plex polymer charged with biological activity. Chem. Rev. 105,
2745–2764.
3. Petitou, M., and van Boeckel, C.A. (2004). A synthetic antithrombin
III binding pentasaccharide is now a drug! What comes next?
Angew. Chem. Int. Ed. Engl. 43, 3118–3133.
4. Waksman, G., and Herr, A.B. (1998). New insights into heparin-
induced FGF oligomerization. Nat. Struct. Biol. 5, 527–530.
5. Pellegrini, L., Burke, D.F., von Delft, F., Mulloy, B., and Blundell,
T.L. (2000). Crystal structure of fibroblast growth factor receptor
ectodomain bound to ligand and heparin. Nature 407, 1029–1034.
6. Powell, A.K., Yates, E.A., Fernig, D.G., and Turnbull, J.E. (2004). In-
teractions of heparin/heparan sulfate with proteins: appraisal of
structural factors and experimental approaches. Glycobiology
14, 17R–30R.
7. Jemth, P., Kreuger, J., Kusche-Gullberg, M., Sturiale, L., Gimenez-
Gallego, G., and Lindahl, U. (2002). Biosynthetic oligosaccharide
libraries for identification of protein-binding heparan sulfate motifs.
Exploring the structural diversity by screening for fibroblast growth
factor (FGF)1 and FGF2 binding. J. Biol. Chem. 277, 30567–30573.
8. Ishihara, M., Tyrrell, D.J., Stauber, G.B., Brown, S., Cousens, L.S.,
and Stack, R.J. (1993). Preparation of affinity-fractionated, hepa-
rin-derived oligosaccharides and their effects on selected biolog-
ical activities mediated by basic fibroblast growth factor. J. Biol.
Chem. 268, 4675–4683.
9. Wu, Z.L., Zhang, L., Yabe, T., Kuberan, B., Beeler, D.L., Love, A.,
and Rosenberg, R.D. (2003). The involvement of heparan sulfate
(HS) in FGF1/HS/FGFR1 signaling complex. J. Biol. Chem. 278,
17121–17129.
10. Feitsma, K., Hausser, H., Robenek, H., Kresse, H., and Vischer, P.
(2000). Interaction of thrombospondin-1 and heparan sulfate from
endothelial cells. Structural requirements of heparan sulfate. J.
Biol. Chem. 275, 9396–9402.
11. Pisano, C., Aulicino, C., Vesci, L., Casu, B., Naggi, A., Torri, G.,
Ribatti, D., Belleri, M., Rusnati, M., and Presta, M. (2005). Under-
sulfated, low-molecular-weight glycol-split heparin as an antian-
giogenic VEGF antagonist. Glycobiology 15, 1C–6C.
12. Foxall, C., Holme, K.R., Liang, W., and Wei, Z. (1995). An enzyme-
linked immunosorbent assay using biotinylated heparan sulfate tolsevier Ltd All rights reserved
Chemistry & Biology
Glycosaminoglycan Microarraysevaluate the interactions of heparin-like molecules and basic fibro-
blast growth factor. Anal. Biochem. 231, 366–373.
13. Sweeney, M.D., Yu, Y., and Leary, J.A. (2006). Effects of sulfate
position on heparin octasaccharide binding to CCL2 examined
by tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 17,
1114–1119.
14. Keiser, N., Venkataraman, G., Shriver, Z., and Sasisekharan, R.
(2001). Direct isolation and sequencing of specific protein-binding
glycosaminoglycans. Nat. Med. 7, 123–128.
15. Ibrahimi, O.A., Zhang, F., Hrstka, S.C., Mohammadi, M., and
Linhardt, R.J. (2004). Kinetic model for FGF, FGFR, and proteo-
glycan signal transduction complex assembly. Biochemistry 43,
4724–4730.
16. Zhang, F., Ronca, F., Linhardt, R.J., and Margolis, R.U. (2004).
Structural determinants of heparan sulfate interactions with Slit
proteins. Biochem. Biophys. Res. Commun. 317, 352–357.
17. Thompson, L.D., Pantoliano, M.W., and Springer, B.A. (1994).
Energetic characterization of the basic fibroblast growth factor-
heparin interaction: identification of the heparin binding domain.
Biochemistry 33, 3831–3840.
18. Feizi, T., Fazio, F., Chai, W., and Wong, C.H. (2003). Carbohydrate
microarrays - a new set of technologies at the frontiers of glyco-
mics. Curr. Opin. Struct. Biol. 13, 637–645.
19. Wang, D. (2003). Carbohydrate microarrays. Proteomics 3, 2167–
2175.
20. Huang, C.Y., Thayer, D.A., Chang, A.Y., Best, M.D., Hoffmann, J.,
Head, S., and Wong, C.H. (2006). Carbohydrate microarray for
profiling the antibodies interacting with Globo H tumor antigen.
Proc. Natl. Acad. Sci. USA 103, 15–20.
21. Adams, E.W., Ratner, D.M., Bokesch, H.R., McMahon, J.B.,
O’Keefe, B.R., and Seeberger, P.H. (2004). Oligosaccharide and
glycoprotein microarrays as tools in HIV glycobiology: glycan-
dependent gp120/protein interactions. Chem. Biol. 11, 875–881.
22. Gama, C.I., Tully, S.E., Sotogaku, N., Clark, P.M., Rawat, M.,
Vaidehi, N., Goddard, W.A., 3rd, Nishi, A., and Hsieh-Wilson,
L.C. (2006). Sulfation patterns of glycosaminoglycans encode
molecular recognition and activity. Nat. Chem. Biol. 2, 467–473.
23. Tully, S.E., Rawat, M., and Hsieh-Wilson, L.C. (2006). Discovery of
a TNF-a antagonist using chondroitin sulfate microarrays. J. Am.
Chem. Soc. 128, 7740–7741.
24. Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt, M.E., Alvarez,
R., Bryan, M.C., Fazio, F., Calarese, D., Stevens, J., et al. (2004).
Printed covalent glycan array for ligand profiling of diverse glycan
binding proteins. Proc. Natl. Acad. Sci. USA 101, 17033–17038.
25. de Paz, J.L., Noti, C., and Seeberger, P.H. (2006). Microarrays of
synthetic heparin oligosaccharides. J. Am. Chem. Soc. 128,
2766–2767.
26. Park, S., Lee, M.R., Pyo, S.J., and Shin, I. (2004). Carbohydrate
chips for studying high-throughput carbohydrate-protein interac-
tions. J. Am. Chem. Soc. 126, 10794.
27. Fukui, S., Feizi, T., Galustian, C., Lawson, A.M., and Chai, W.
(2002). Oligosaccharide microarrays for high-throughput detec-
tion and specificity assignments of carbohydrate-protein interac-
tions. Nat. Biotechnol. 20, 1011–1017.
28. Houseman, B.T., and Mrksich, M. (2002). Carbohydrate arrays for
the evaluation of protein binding and enzymatic modification.
Chem. Biol. 9, 443–454.
29. Zhi, Z.L., Powell, A.K., and Turnbull, J.E. (2006). Fabrication of
carbohydrate microarrays on gold surfaces: direct attachment of
nonderivatized oligosaccharides to hydrazide-modified self-
assembled monolayers. Anal. Chem. 78, 4786–4793.
30. Carion, O., Lefebvre, J., Dubreucq, G., Dahri-Correia, L., Correia,
J., and Melnyk, O. (2006). Polysaccharide microarrays for polysac-Chemistry & Biology 14, 195–2charide-platelet-derived-growth-factor interaction studies. Chem-
BioChem 7, 817–826.
31. Willats, W.G., Rasmussen, S.E., Kristensen, T., Mikkelsen, J.D.,
and Knox, J.P. (2002). Sugar-coated microarrays: a novel slide
surface for the high-throughput analysis of glycans. Proteomics
2, 1666–1671.
32. Pirrung, M.C. (2002). How to make a DNA chip. Angew. Chem. Int.
Ed. Engl. 41, 1277–1289.
33. Schena, M., Shalon, D., Davis, R.W., and Brown, P.O. (1995).
Quantitative monitoring of gene expression patterns with a com-
plementary DNA microarray. Science 270, 467–470.
34. Maccarana, M., Casu, B., and Lindahl, U. (1993). Minimal se-
quence in heparin/heparan sulfate required for binding of basic fi-
broblast growth factor. J. Biol. Chem. 268, 23898–23905.
35. Pankonin, M.S., Gallagher, J.T., and Loeb, J.A. (2005). Specific
structural features of heparan sulfate proteoglycans potentiate
neuregulin-1 signaling. J. Biol. Chem. 280, 383–388.
36. Spillmann, D., Witt, D., and Lindahl, U. (1998). Defining the inter-
leukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273,
15487–15493.
37. Ornitz, D.M., and Itoh, N. (2001). Fibroblast growth factors. Ge-
nome Biol. 2, Reviews3005.
38. Lustig, F., Hoebeke, J., Ostergren-Lunden, G., Velge-Roussel, F.,
Bondjers, G., Olsson, U., Ruetschi, U., and Fager, G. (1996). Alter-
native splicing determines the binding of platelet-derived growth
factor (PDGF-AA) to glycosaminoglycans. Biochemistry 35,
12077–12085.
39. Vives, R.R., Sadir, R., Imberty, A., Rencurosi, A., and Lortat-Jacob,
H. (2002). A kinetics and modeling study of RANTES(9–68) binding
to heparin reveals a mechanism of cooperative oligomerization.
Biochemistry 41, 14779–14789.
40. Nugent, M.A., and Edelman, E.R. (1992). Kinetics of basic fibro-
blast growth factor binding to its receptor and heparan sulfate pro-
teoglycan: a mechanism for cooperactivity. Biochemistry 31,
8876–8883.
41. Delehedde, M., Lyon, M., Gallagher, J.T., Rudland, P.S., and
Fernig, D.G. (2002). Fibroblast growth factor-2 binds to small
heparin-derived oligosaccharides and stimulates a sustained
phosphorylation of p42/44 mitogen-activated protein kinase
and proliferation of rat mammary fibroblasts. Biochem. J. 366,
235–244.
42. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., and Rees,
D.C. (1996). Heparin structure and interactions with basic fibro-
blast growth factor. Science 271, 1116–1120.
43. Faham, S., Linhardt, R.J., and Rees, D.C. (1998). Diversity does
make a difference: fibroblast growth factor-heparin interactions.
Curr. Opin. Struct. Biol. 8, 578–586.
44. Schlessinger, J., Plotnikov, A.N., Ibrahimi, O.A., Eliseenkova, A.V.,
Yeh, B.K., Yayon, A., Linhardt, R.J., and Mohammadi, M. (2000).
Crystal structure of a ternary FGF-FGFR-heparin complex reveals
a dual role for heparin in FGFR binding and dimerization. Mol. Cell
6, 743–750.
45. Ashikari-Hada, S., Habuchi, H., Kariya, Y., Itoh, N., Reddi, A.H.,
and Kimata, K. (2004). Characterization of growth factor-binding
structures in heparin/heparan sulfate using an octasaccharide li-
brary. J. Biol. Chem. 279, 12346–12354.
46. Kariya, Y., Kyogashima, M., Suzuki, K., Isomura, T., Sakamoto, T.,
Horie, K., Ishihara, M., Takano, R., Kamei, K., and Hara, S. (2000).
Preparation of completely 6-O-desulfated heparin and its ability to
enhance activity of basic fibroblast growth factor. J. Biol. Chem.
275, 25949–25958.
47. Kreuger, J., Prydz, K., Pettersson, R.F., Lindahl, U., and Salmivirta,
M. (1999). Characterization of fibroblast growth factor 1 binding
heparan sulfate domain. Glycobiology 9, 723–729.08, February 2007 ª2007 Elsevier Ltd All rights reserved 207
Chemistry & Biology
Glycosaminoglycan Microarrays48. Lavine, K.J., Yu, K., White, A.C., Zhang, X., Smith, C., Partanen, J.,
and Ornitz, D.M. (2005). Endocardial and epicardial derived FGF
signals regulate myocardial proliferation and differentiation
in vivo. Dev. Cell 8, 85–95.
49. Hoshikawa, M., Ohbayashi, N., Yonamine, A., Konishi, M., Ozaki,
K., Fukui, S., and Itoh, N. (1998). Structure and expression of
a novel fibroblast growth factor, FGF-17, preferentially expressed
in the embryonic brain. Biochem. Biophys. Res. Commun. 244,
187–191.
50. Brickman, Y.G., Ford, M.D., Gallagher, J.T., Nurcombe, V.,
Bartlett, P.F., and Turnbull, J.E. (1998). Structural modification
of fibroblast growth factor-binding heparan sulfate at a determi-
native stage of neural development. J. Biol. Chem. 273, 4350–
4359.
51. Yabe, T., Hata, T., He, J., and Maeda, N. (2005). Developmental
and regional expression of heparan sulfate sulfotransferase genes
in the mouse brain. Glycobiology 15, 982–993.
52. Ford-Perriss, M., Guimond, S.E., Greferath, U., Kita, M., Grobe, K.,
Habuchi, H., Kimata, K., Esko, J.D., Murphy, M., and Turnbull, J.E.
(2002). Variant heparan sulfates synthesized in developing mouse
brain differentially regulate FGF signaling. Glycobiology 12, 721–
727.
53. Nurcombe, V., Ford, M.D., Wildschut, J.A., and Bartlett, P.F.
(1993). Developmental regulation of neural response to FGF-1
and FGF-2 by heparan sulfate proteoglycan. Science 260, 103–
106.
54. Hu, H. (2001). Cell-surface heparan sulfate is involved in the repul-
sive guidance activities of Slit2 protein. Nat. Neurosci. 4, 695–701.
55. Skutella, T., and Nitsch, R. (2001). New molecules for hippocampal
development. Trends Neurosci. 24, 107–113.
56. Klein, R. (2004). Eph/ephrin signaling in morphogenesis, neural de-
velopment and plasticity. Curr. Opin. Cell Biol. 16, 580–589.
57. Raper, J.A. (2000). Semaphorins and their receptors in vertebrates
and invertebrates. Curr. Opin. Neurobiol. 10, 88–94.
58. Kantor, D.B., Chivatakarn, O., Peer, K.L., Oster, S.F., Inatani, M.,
Hansen, M.J., Flanagan, J.G., Yamaguchi, Y., Sretavan, D.W.,
Giger, R.J., and Kolodkin, A.L. (2004). Semaphorin 5A is a bifunc-
tional axon guidance cue regulated by heparan and chondroitin
sulfate proteoglycans. Neuron 44, 961–975.
59. Pasquale, E.B. (2005). Eph receptor signalling casts a wide net on
cell behaviour. Nat. Rev. Mol. Cell Biol. 6, 462–475.208 Chemistry & Biology 14, 195–208, February 2007 ª2007 El60. Bulow, H.E., and Hobert, O. (2004). Differential sulfations and
epimerization define heparan sulfate specificity in nervous system
development. Neuron 41, 723–736.
61. Grobe, K., Inatani, M., Pallerla, S.R., Castagnola, J., Yamaguchi,
Y., and Esko, J.D. (2005). Cerebral hypoplasia and craniofacial de-
fects in mice lacking heparan sulfate Ndst1 gene function. Devel-
opment 132, 3777–3786.
62. Irie, A., Yates, E.A., Turnbull, J.E., and Holt, C.E. (2002). Specific
heparan sulfate structures involved in retinal axon targeting. De-
velopment 129, 61–70.
63. Kinnunen, T., Huang, Z., Townsend, J., Gatdula, M.M., Brown,
J.R., Esko, J.D., and Turnbull, J.E. (2005). Heparan 2-O-sulfotrans-
ferase, hst-2, is essential for normal cell migration in Caenorhabdi-
tis elegans. Proc. Natl. Acad. Sci. USA 102, 1507–1512.
64. Deepa, S.S., Umehara, Y., Higashiyama, S., Itoh, N., and
Sugahara, K. (2002). Specific molecular interactions of over-
sulfated chondroitin sulfate E with various heparin-binding
growth factors. Implications as a physiological binding part-
ner in the brain and other tissues. J. Biol. Chem. 277,
43707–43716.
65. Chen, J.H., Wen, L., Dupuis, S., Wu, J.Y., and Rao, Y. (2001). The
N-terminal leucine-rich regions in Slit are sufficient to repel olfac-
tory bulb axons and subventricular zone neurons. J. Neurosci.
21, 1548–1556.
66. Liu, G., Beggs, H., Jurgensen, C., Park, H.T., Tang, H., Gorski, J.,
Jones, K.R., Reichardt, L.F., Wu, J., and Rao, Y. (2004). Netrin re-
quires focal adhesion kinase and Src family kinases for axon out-
growth and attraction. Nat. Neurosci. 7, 1222–1232.
67. Taylor, K.A., and Buchanan-Smith, J.G. (1992). A colorimetric
method for the quantitation of uronic acids and a specific assay
for galacturonic acid. Anal. Biochem. 201, 190–196.
68. Fan, C.M., and Tessier-Lavigne, M. (1994). Patterning of mamma-
lian somites by surface ectoderm and notochord: evidence for
sclerotome induction by a hedgehog homolog. Cell 79, 1175–
1186.
69. Ward, M.E., and Rao, Y. (2005). Investigations of neuronal migra-
tion in the central nervous system. Methods Mol. Biol. 294, 137–
156.
70. Zhu, Y., Li, H., Zhou, L., Wu, J.Y., and Rao, Y. (1999). Cellular and
molecular guidance of GABAergic neuronal migration from an ex-
tracortical origin to the neocortex. Neuron 23, 473–485.sevier Ltd All rights reserved
